TSHA
$4.11+4.31%
Taysha Gene Therapies Inc.Stock · HealthcareRussell 2000 · 0.05% of IWMNasdaq Composite · 0.005% of ONEQUS Stock Market · 0.003% of VTIRussell 3000 · 0.002% of IWV
TSHA financial statements
The full income statement, balance sheet, and cash-flow statement for Taysha Gene Therapies Inc. (TSHA), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 204.9M2024-09 204.9M2024-12 205.0M2025-03 214.7M2025-06 272.8M2025-09 273.9M2025-12 287.3M2026-03 287.4M2026-06 325.8M+59.0% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 9.77M+17.3% | 8.33M-46.1% | 15.5M+517.5% | 2.50M | — | |
| 120M+20.5% | 99.8M+13.5% | 87.9M-46.7% | 165M-4.8% | 173M | ||
| Research & development | 86.4M+30.9% | 66.0M+16.2% | 56.8M-37.7% | 91.2M-30.9% | 132M | |
| Selling, general & administrative | 33.9M+17.0% | 29.0M-3.6% | 30.0M-19.6% | 37.4M-9.6% | 41.3M | |
| General & administrative | 33.9M+17.0% | 29.0M-3.6% | 30.0M-19.6% | 37.4M-9.6% | 41.3M | |
| Operating income | -110M-20.8% | -91.5M-26.3% | -72.4M+55.4% | -162M+6.2% | -173M | |
| Interest expense | 63.0K-38.2% | 102K-98.0% | 5.00M+31.6% | 3.80M+166.0% | 1.43M | |
| Interest & investment income | 9.22M+32.9% | 6.94M+94.3% | 3.57M | — | — | |
| Other non-operating income | -291K-164.5% | -110K-134.0% | -47.0K+98.7% | -3.57M-184.0% | -1.26M | |
| Income tax | 0.00 | 0.00 | 0.00 | 0.00 | — | |
| -109M-22.1% | -89.3M+20.0% | -112M+32.8% | -166M+4.9% | -175M | ||
| Net income to common | -109M-22.1% | -89.3M+20.0% | -112M+32.8% | -166M+4.9% | -175M | |
| -$0.34+5.6% | -$0.36+62.5% | -$0.96+74.6% | -$3.78+18.5% | -$4.64 | ||
| EPS (basic) | -$0.34+5.6% | -$0.36+62.5% | -$0.96+74.6% | -$3.78+18.5% | -$4.64 | |
| Weighted-avg shares (basic) | 320M+27.8% | 250M+115.4% | 116M+164.2% | 44.0M+16.7% | 37.7M | |
| Weighted-avg shares (diluted) | 320M+27.8% | 250M+115.4% | 116M+164.2% | 44.0M+16.7% | 37.7M | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 325M+128.4% | 142M-5.2% | 150M+55.4% | 96.4M-39.6% | 160M-38.1% | ||
| Cash & equivalents | 320M+130.0% | 139M-3.4% | 144M+63.8% | 87.9M-41.1% | 149M-40.7% | |
| Prepaid expenses | 4.43M+67.5% | 2.65M-24.0% | 3.48M-59.2% | 8.54M-18.7% | 10.5M+58.5% | |
| Other current assets | 802K+160.4% | 308K+5.5% | 292K-37.3% | 466K-46.0% | 863K+160.7% | |
| 343M+114.1% | 160M-7.2% | 173M+36.8% | 126M-41.0% | 214M-17.4% | ||
| Property, plant & equipment | 6.74M-10.0% | 7.49M-30.9% | 10.8M-27.6% | 15.0M-70.4% | 50.6M+17534.1% | |
| Operating lease right-of-use | 9.44M+12.6% | 8.38M-12.5% | 9.58M-12.4% | 10.9M | — | |
| Other non-current assets | 183K-15.7% | 217K-28.6% | 304K-76.9% | 1.32M+18.9% | 1.11M | |
| 26.6M+1.2% | 26.2M-28.6% | 36.8M-41.5% | 62.8M+21.3% | 51.7M+625.9% | ||
| Accounts payable | 6.28M+74.7% | 3.59M-43.6% | 6.37M-41.8% | 10.9M-49.7% | 21.8M+991.4% | |
| Deferred revenue | — | 9.77M-46.0% | 18.1M-46.0% | 33.6M | — | |
| Current lease liability | 1.49M+0.0% | 1.49M+15.0% | 1.29M+7.6% | 1.20M | — | |
| Other current liabilities | — | — | — | — | 1.49M+1538.5% | |
| Finance lease liability (current) | 379K-3.1% | 391K+10.5% | 354K+10.6% | 320K | — | |
| 96.4M+8.5% | 88.8M-9.2% | 97.8M-22.0% | 125M+5.7% | 119M+1464.5% | ||
| Long-term debt | 50.1M+14.0% | 43.9M+8.5% | 40.5M+6.7% | 38.0M+2.1% | 37.2M | |
| Non-current lease liability | 18.2M+4.7% | 17.4M-8.4% | 19.0M-7.3% | 20.4M | — | |
| Operating lease liability (total) | 19.7M+4.3% | 18.8M-6.9% | 20.2M-6.5% | 21.6M | — | |
| Finance lease liability (total) | 379K-50.8% | 770K-32.0% | 1.13M-22.0% | 1.45M | — | |
| Finance lease liability | — | 379K-51.3% | 778K-31.3% | 1.13M | — | |
| Other non-current liabilities | 1.55M+18.6% | 1.31M-17.0% | 1.58M-61.8% | 4.13M+10.6% | 3.73M+730.0% | |
| 247M+245.2% | 71.5M-4.6% | 74.9M+7796.4% | 949K-99.0% | 95.4M-62.0% | ||
| Common stock | 3.00K+50.0% | 2.00K+0.0% | 2.00K+100.0% | 1.00K | — | |
| Additional paid-in capital | 958M+41.4% | 678M+15.3% | 588M+46.1% | 402M+21.6% | 331M+6.0% | |
| Retained earnings | -711M-18.1% | -602M-17.4% | -513M-27.8% | -401M-70.4% | -236M-285.5% | |
| Accumulated other comprehensive income | -192K+95.2% | -4.03M | — | — | — | |
| Total liabilities & equity | 343M+114.1% | 160M-7.2% | 173M+36.8% | 126M-41.0% | 214M-17.4% | |
| Common shares issued | 285M+39.1% | 205M+9.6% | 187M+195.8% | 63.2M+64.3% | 38.5M+1.9% | |
| Common shares outstanding | 285M+39.1% | 205M+9.6% | 187M+195.8% | 63.2M+64.3% | 38.5M+1.9% | |
| Shares outstanding (cover) | 287M+40.1% | 205M+9.6% | 187M+194.6% | 63.5M | — | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -93.1M-14.6% | -81.2M-11.2% | -73.0M+17.4% | -88.4M+24.5% | -117M | ||
| Depreciation & amortization | 1.15M-8.0% | 1.25M-9.2% | 1.37M+17.0% | 1.17M+138.2% | 492K | |
| Share-based compensation | 13.3M+1.5% | 13.1M+65.8% | 7.91M-56.2% | 18.0M-0.8% | 18.2M | |
| Change in payables | -153K+94.8% | -2.92M-27.2% | -2.29M+70.6% | -7.80M-153.8% | 14.5M | |
| -604K-66.4% | -363K+95.1% | -7.35M+70.5% | -24.9M-15.7% | -21.6M | ||
| Capital expenditure | 738K+97.3% | 374K-90.3% | 3.87M-81.2% | 20.6M+34.7% | 15.3M | |
| Free cash flow | -93.8M-15.0% | -81.6M-6.1% | -76.9M+29.5% | -109M+17.6% | -132M | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other investing activities | -134K-1118.2% | -11.0K+35.3% | -17.0K-127.9% | 61.0K | — | |
| 275M+258.1% | 76.7M-43.8% | 136M+161.8% | 52.1M+33.3% | 39.1M | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00-100.0% | 500K | 0.00 | 0.00 | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other financing activities | -337K-101.8% | -167K+27.1% | -229K+78.0% | -1.04M-102.7% | -514K | |
| Net change in cash | 181M+3788.7% | -4.90M-108.8% | 56.0M+191.5% | -61.2M+38.5% | -99.5M | |
| Interest paid | 5.40M+2.2% | 5.28M+6.7% | 4.95M+78.5% | 2.77M+332.9% | 641K | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 1.58B+345.5% | 355M+7.2% | 331M+134.5% | 141M-68.5% | 448M-55.3% | |
| P/S | 161.7×+279.9% | 42.6×-67.8% | 132.3× | — | — | |
| P/B | 6.4×+29.0% | 5.0× | — | 13.2×+180.6% | 4.7×+17.8% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: TSHA’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all TSHA filings on SEC EDGAR → Not investment advice.